tci Part B Insider - 2012 Issue 21

Reader Question: Don't Blithely Report Cancer Diagnoses

Question: My physician removed a patient's second lesion. The path reported severe dysplastic junctional melanocytic nevus exhibiting severe architectural disorder and melanocytic cytologic atypia with features of regression extending to the section edge. He noted that "Re-excision is required." Should I bill from the 11600-11646 series? The first lesion removal was billed as benign.Answer: This is still not cancer, but the doctor needed to remove this type of lesion because it puts the patient at risk for developing melanoma. Remember, you should always be cautious when applying a cancer diagnosis to a patient's claim, because this...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.